RE-BVS – Piemonte Repository

Sfoglia per AUTORE
GORLA R
Collezione AO Ordine Mauriziano

Items : 11

Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2024 Jan;42(1):104-114. doi: 10.55563/clinexprheumatol/q38lu0. Epub 2023 Aug 30.

2024
AOU Città della Salute di Torino
AO Ordine Mauriziano

Lapadula G; Ramonda R; Rossini M; Salaffi F; Santo L; Sarzi Puttini P; Sebastiani M; Semerano A; Ferraccioli G; Iannone F; Parisi S; Iagnocco A; Govoni M; Gremese E; Guiducci S; Gerli R; Gorla R; Frediani B; Foti R; Chimenti MS; Conti F; Corrado A; Carletto A; Cauli A; Bugatti S; Atzeni F; Caporali R; Collesei A; Doria A; et alii...

Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Mar-Apr;39(2):263-268. doi: 10.55563/clinexprheumatol/q69z52. Epub 2020 Jun

2021
AO Ordine Mauriziano
AOU Alessandria
AOU Città della Salute di Torino

Capri S; Sinigaglia L; Stobbione P; Sarzi-Puttini P; Lomater C; Gorla R; Fusaro E; Caporali R; Manara M;

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. in International journal of rheumatic diseases / Int J Rheum Dis. 2018 Feb;21(2):422-430. doi: 10.1111/1756-185X.13199. Epub 2017 Oct 30.

2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Favalli EG; Sinigaglia L; Becciolini A; Grosso V; Gorla R; Bazzani C; Atzeni F; Sarzi Puttini PC; Fusaro E; Pellerito R; Caporali R;

Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Sep-Oct;35(5):804-809. Epub 2017 Jul 27.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino

Sinigaglia L; Rocchetta PA; Pellerito R; Bazzani C; Fusaro E; Gorla R; Sarzi Puttini P; Atzeni F; Grosso V; Favalli EG; Caporali R; Manara M;

Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. in Clinical rheumatology / Clin Rheumatol. 2017 Apr;36(4):753-761. doi: 10.1007/s10067-016-3528-y. Epub 2017 Jan 5.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino

Favalli EG; Marchesoni A; Rocchetta PA; Fusaro E; Paolazzi G; Atzeni F; Pellerito R; Sarzi-Puttini P; Klersy C; Gorla R; Caporali R; Monti S;

Golimumab efficacy in rheumatoid arthritis after conventional and biological treatment: Data from the Italian LORHEN registry in Annals of the Rheumatic Diseases

2016
AOU Città della Salute di Torino
AO Ordine Mauriziano

Grosso V; Gorla R; Sarzi-Puttini P; Atzeni F; Pellerito R; Fusaro E; Paolazzi G; Rocchetta PA; Favalli EG; Marchesoni A; Caporali R;

Factors influencing the choice of first and second line biologic therapy for the treatment of rheumatoid arthritis: Real life data from the Italian LORHEN registry in Annals of the Rheumatic Diseases

2016
AOU Città della Salute di Torino
AO Ordine Mauriziano

Monti S; Gorla R; Sarzi-Puttini P; Atzeni F; Pellerito R; Fusaro E; Paolazzi G; Rocchetta PA; Favalli EG; Marchesoni A; Caporali R;

Golimumab therapy retention rates in patients with rheumatoid arthritis and seronegative spondyloarthritis: Data from the Italian LORHEN registry in Annals of the Rheumatic Diseases

2015
AOU Città della Salute di Torino
AO Ordine Mauriziano

Grosso V; Gorla R; Sarzi-Puttini P; Atzeni F; Pellerito R; Fusaro E; Paolazzi G; Rocchetta PA; Favalli EG; Marchesoni A; Caporali R;

Fifteen years of biological treatment for rheumatoid arthritis: Data from the Italian Lorhen registry in Annals of the Rheumatic Diseases

2015
AOU Città della Salute di Torino
AO Ordine Mauriziano

Grosso V; Gorla R; Sarzi-Puttini P; Atzeni F; Pellerito R; Fusaro E; Paolazzi G; Rocchetta PA; Favalli EG; Marchesoni A; Caporali R;

Comorbidities influence the choice of the biologic agent: Real life data from the Lorhen registry in Annals of the Rheumatic Diseases

2015
AOU Città della Salute di Torino
AO Ordine Mauriziano

Monti S; Gorla R; Sarzi-Puttini P; Atzeni F; Pellerito R; Fusaro E; Paolazzi G; Rocchetta PA; Favalli E; Marchesoni A; Caporali R;

Remission in early, aggressive rheumatoid arthritis: A multicentre prospective observational Italian study ARPA (Artrite reumatoide precoce Aggressiva) in Clinical and Experimental Rheumatology

2013
AO Ordine Mauriziano

Ceccarelli F; Perricone C; Trotta F; Cuomo G; Pellerito R; Bagnato G; Salaffi F; Caporali R; Cutolo M; Galeazzi M; Fiocco U; Lapadula G; Bombardieri S; Bianchi G; Gorla R; Giardina A; Gallo G; Giardino AM; Valesini G;